SCHEMBL12481558

SCHEMBL12481558

O=C(NC(Cc1ccc(-c2ccccc2)cc1)CC(CO)C(=O)O)c1nc(O)n[nH]1

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.68
▸ ACE P12821 5/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11969919 1.00 MME (0.68) MMEACE
SCHEMBL11970082 0.89 MME (0.72) MMEACE
SCHEMBL11969621 0.89 MME (0.67) MMEACE
SCHEMBL11969967 0.89 MME (0.55) MMEACE
SCHEMBL12481447 0.89 MME (0.55) MMEACE
SCHEMBL11969684 0.82 MME (0.88) MMEACE
SCHEMBL16278283 0.82 MME (0.68) MMEACE
SCHEMBL11969698 0.82 MME (0.88) MMEACE
SCHEMBL11969689 0.82 MME (0.88) MMEACE
SCHEMBL11969829 0.82 MME (0.76) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675795-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-12-25 — — EP disclosed
WO-2012112742-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-08-23 — — WO disclosed
Send feedback